Best of Twitter - Week of January 17, 2022
In the early days of Segment, right after we crossed $10m ARR our growth decelerated 8x from 300% yoy to 40% yoy in 6 months. What the hell happened? How did we reaccelerate back to 100% yoy? A thread 1/18
^ startups are hard
Really enjoying Razib Khan's latest post ($) on population turnover in Britain. Esp the bit below captures the gist. Recommended.👍
razib.substack.com/p/the-sun-neve…
^ wow
Switching from a 10- to a 5- day course means not giving patients five days of unnecessary antibiotics, and drops total use by half.
Studies like this should be a priority for antibiotic stewardship. In how many other cases are we giving too many abx to already-recovered pts?
NIAID News @NIAIDNews
^ also: https://www.bmj.com/content/358/bmj.j3418.full
Blogged today about AlphaFold excitement, based on this thread from the other day:
science.org/content/blog-p…
Russell Kaplan @russelljkaplan
Abundance requires innovation.
Innovation begins with science.
But scientific funding in the U.S. is broken—it's too slow, risk-averse, and old.
I wrote about a surprising coalition of tech founders and star scientists who are trying to fix it.
^ New Science profiled! (along with Arcadia and Arc)
Outstanding history and business strategy write up about Intel and TSMC from Ben Thompson today 👍
Below is one of the key bits.
stratechery.com/2022/the-intel…
A 2021 study of 265,172 subjects in Sweden over a 12-year period found that patients with herpes diagnoses not treated with antiviral drugs had a 50% increased risk of dementia over controls, but treatment with antiviral drugs reduced the incidence by 25%.
